Two new appointments at Unigene
This article was originally published in SRA
Executive Summary
Unigene Laboratories, a US-based company focused on the design, delivery, manufacture and development of peptide-based therapeutics, has appointed Gregory Mayes to the newly created position of vice president, corporate affairs and general counsel, and has promoted Roxanne Tavakkol to vice president of global regulatory affairs.